Are Ishan Dyes and chemicals Ltd latest results good or bad?

2 hours ago
share
Share Via
Ishan Dyes and Chemicals Ltd's latest results show a strong quarterly performance with significant revenue growth and a return to profitability; however, the company faces long-term operational challenges, high debt levels, and low return on equity, indicating potential financial strain.
Ishan Dyes and Chemicals Ltd's latest financial results for the quarter ended March 2026 indicate a significant operational turnaround. The company reported net sales of ₹31.76 crores, reflecting a year-on-year growth of 89.84% and a sequential increase of 69.93% from the previous quarter. This marks the highest quarterly revenue in at least two years, suggesting a potential recovery in demand for its core products.
The net profit for the quarter was ₹1.46 crores, a notable improvement compared to a loss of ₹5.25 crores in the prior quarter. This shift to profitability is complemented by an operating margin of 17.57%, which is a substantial recovery from the negative margins recorded in previous quarters. The profit after tax (PAT) margin also improved to 4.60%, up from -28.09% in the previous quarter. Despite these positive indicators, the company's long-term operational metrics reveal underlying challenges. Ishan Dyes has experienced a five-year decline in operating profits at a compound annual growth rate (CAGR) of -183%, alongside a sales CAGR of -4.70%. Additionally, the company faces high levels of debt, with a debt-to-EBITDA ratio of 5.95 times and an interest coverage ratio of just 1.99 times, indicating potential financial strain. Moreover, the reliance on other income, which constituted a significant portion of profit before tax in the latest quarter, raises questions about the sustainability of the reported earnings. The company's average return on equity (ROE) remains low at 5.33%, significantly trailing its peers in the specialty chemicals sector. In summary, while Ishan Dyes and Chemicals Ltd has demonstrated a strong quarterly performance with signs of recovery, the broader financial context reveals persistent operational challenges and high leverage. The company saw an adjustment in its evaluation, reflecting these complexities in its financial health.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News